Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.
about
De novo design and synthesis of ultra-short peptidomimetic antibiotics having dual antimicrobial and anti-inflammatory activities.Acyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microfloraTranscriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance."Specificity Determinants" Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 Against the Gram-negative Pathogens Acinetobacter baumannii and Pseudomonas aeruginosaTherapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis.A miniature mimic of host defense peptides with systemic antibacterial efficacy.Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.Anti-Pseudomonas activity of frog skin antimicrobial peptides in a Caenorhabditis elegans infection model: a plausible mode of action in vitro and in vivo.Underlying mechanism of in vivo and in vitro activity of C-terminal-amidated thanatin against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coliBiological properties of novel antistaphylococcal quinoline-indole agents.R-thanatin inhibits growth and biofilm formation of methicillin-resistant Staphylococcus epidermidis in vivo and in vitro.A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococciAntiplasmodial properties of acyl-lysyl oligomers in culture and animal models of malaria.In vivo efficacy of anuran trypsin inhibitory peptides against staphylococcal skin infection and the impact of peptide cyclizationAntimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilmsDe novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia.In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria.The Disulfide Bond of the Peptide Thanatin Is Dispensible for Its Antimicrobial Activity In Vivo and In Vitro.Antibacterial properties and mode of action of a short acyl-lysyl oligomer.De novo designed synthetic mimics of antimicrobial peptides.Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin.In vitro antibacterial activity of acyl-lysyl oligomers against Helicobacter pylori.Dermaseptins and magainins: antimicrobial peptides from frogs' skin-new sources for a promising spermicides microbicides-a mini review.A New Synthetic Peptide Having Two Target of Antibacterial Action in E. coli ML35.In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2.In vitro activities of dermaseptins K4S4 and K4K20S4 against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa planktonic growth and biofilm formation.Antiplasmodial activity of lauryl-lysine oligomers.Antimicrobial activity and stability of protonectin with D-amino acid substitutions.Efficacy of Yeast' Vacuoles as Antimicrobial Agents to Escherichia coli Bacteremia in Rat.Biodegradable Antimicrobial Polycarbonates with In Vivo Efficacy against Multidrug-Resistant MRSA Systemic Infection.Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers.The synthetic antimicrobial peptide pexiganan and its nanoparticles (PNPs) exhibit the anti-helicobacter pylori activity in vitro and in vivo.Clavanin A improves outcome of complications from different bacterial infectionsIn vitro potential of Lycosin-I as an alternative antimicrobial drug for treatment of multidrug-resistant Acinetobacter baumannii infections.Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives.Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics.Induction of the Cpx envelope stress pathway contributes to Escherichia coli tolerance to antimicrobial peptides.Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides.Antibacterial properties of dermaseptin S4 derivatives under extreme incubation conditions.Consequences of N-acylation on structure and membrane binding properties of dermaseptin derivative K4-S4-(1-13).
P2860
Q31145703-B6F09678-173A-4833-9CFE-D1B659A5B476Q33260522-C68C2C28-2E96-47EA-83D5-FC414C57C69DQ33502861-EFC94170-32BD-4251-9FE4-26D55ACDB16CQ33584712-E64C17AB-68F5-4881-89E1-01C6222576DBQ33798039-4842CBBC-81A2-4F33-960B-7C35BEA62E79Q33868731-71C69F72-73EA-4ADD-80FE-51FFEC578D55Q33938255-9F9B4659-B44B-48E8-8252-1FD6981E3434Q34108768-C74706BB-B7F9-4047-8275-14BEA389F2A8Q34763500-3D14D224-04D3-49A5-8E90-4AC41FD60636Q34821242-766FF8A7-2BF8-4B04-BDAE-66E6C7B18EA4Q34896647-3DC94384-E68A-4184-80FA-81B5C6987E21Q35124472-1445452D-4417-4EB3-B433-10C53D17B22CQ35139434-94B12600-C70E-4D3C-A396-0CCEF80BC1DDQ35169096-B9DE13BE-29AB-4398-B101-00DF73539812Q35684711-F1388DF8-E4D3-4F5A-8959-5A17AC40B8F6Q36646981-CF8B3026-878F-4723-9816-5A81A5FB47D6Q36669161-818E436F-1534-4F33-A6AA-CE738A21835EQ37023132-1392B9EA-0B63-4111-9B56-8C9749515E9FQ37274674-D304CD87-2DA2-48A9-999E-0881AB4D67E6Q37321460-8A0A6181-9C5A-4016-917C-1A5228FF4E80Q37325942-8727AE26-922E-4EB3-B53E-E0D397AF6679Q37392936-BD5109C0-AACB-40F5-85C8-4E40EB1D76B2Q37412040-A4F20EF5-71D8-4767-AFB2-61517124BC59Q37516080-C105D6BA-11F8-4826-B6A3-A78502E69442Q39518387-B7F2E434-E6E5-4C64-8DBA-B267A6661BB6Q39684214-611D16E9-58DE-486E-930E-5DF8C7AFB5CDQ40169806-46FDFA9F-1EDB-464D-B6F5-9A1F8200CFD3Q40291998-BAFAA0D9-0F5B-4EA0-AB61-055A2B260916Q40498966-FA9BFB19-BDE8-41FD-8554-32881838E4C5Q40583200-0D78E552-ADEE-4C6B-B721-3C6AD0B514ADQ41390340-862C2320-E348-4798-9BC5-F2BD84B61F19Q41451193-003277C5-A501-4D7F-8F3A-AC3ECC02A70BQ41577433-809909F4-4A73-458A-8006-FE026983C357Q41748766-8DEC2941-E880-4EB6-9B96-5E2938B518F9Q41826503-A70EB922-3159-4876-9732-93510C7C33A1Q41869149-E8DB6140-08BC-49F7-A82B-26797F913128Q42022967-C85FEEB8-8374-4055-9A25-46CAE7FDDAB7Q42140552-F7ED5E4F-BE3F-4FA7-913E-76190975A37CQ42218485-81944017-7913-4326-A3A9-F5F83A136839Q43597969-E8EDC731-75A9-4C58-BCFA-5ADAB62E4732
P2860
Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.
@ast
Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.
@en
Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.
@nl
type
label
Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.
@ast
Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.
@en
Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.
@nl
prefLabel
Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.
@ast
Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.
@en
Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.
@nl
P2093
P2860
P1476
Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.
@en
P2093
Leonid Gaidukov
Rina Feder
Shiri Navon-Venezia
Yehuda Carmeli
P2860
P304
P356
10.1128/AAC.46.3.689-694.2002
P407
P577
2002-03-01T00:00:00Z